Zhitong Finance App News, Zhongheng Group (600252.SH) announced that the company's holding subsidiary, Chongqing Laimei Pharmaceutical Co., Ltd. (“Laimei Pharmaceutical”), has received the “Drug Registration Certificate” of Nicodyl for injections of 2 mg and 12 mg, approved and issued by the State Drug Administration.

Zhitongcaijing · 03/11 10:33
Zhitong Finance App News, Zhongheng Group (600252.SH) announced that the company's holding subsidiary, Chongqing Laimei Pharmaceutical Co., Ltd. (“Laimei Pharmaceutical”), has received the “Drug Registration Certificate” of Nicodyl for injections of 2 mg and 12 mg, approved and issued by the State Drug Administration.